TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | 0 | 12 | 7 | -3 | -35 | -4 |
| P | %wins | 0 | 100 | 100 | 100 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/21 09:22 | 5/13/21 | ELOX | Eloxx Pharmaceuticals, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Parekh Rajesh B | MA | D | P | 3,330 | 1.35 | 0 | 2,467 | 104 | 4,827 | I | |||||||||||||||
9/14/10 13:39 | 9/13/10 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parekh Rajesh R | MA | D | P | 149 | 3.73 | 3 | 40 | New | 40 | D | -60 | -29 | -23 | -23 | -23 | -8 | -14 | 11 | -2 | 0 | 12 | 7 | -3 | -35 | |
9/23/08 18:13 | 9/8/08 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parekh Rajesh R | MA | D | S.m | -630 | 11.21 | 0 | -56 | -100 | 0 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |